https://www.marketscreener.com/quote/stock/PHARMAENGINE-INC-13323367/news/PharmaEngine-Inc-Announces-First-Patient-Dosed-in-Phase-I-Trial-of-Pep07-for-Hematological-Cancers-44653837/?utm_source=telegram&utm_medium=social&utm_campaign=share